Skip to main content
Clinical Trials/NCT03015454
NCT03015454
Completed
Not Applicable

A Randomized Controlled Clinical Trial of an Algorithm Driven Sepsis Prediction Biomarker

Dascena1 site in 1 country142 target enrollmentDecember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sepsis
Sponsor
Dascena
Enrollment
142
Locations
1
Primary Endpoint
Hospital length of stay
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

A sepsis early warning predictive algorithm, InSight, has been developed and validated on a large, diverse patient cohort. In this prospective study, the ability of InSight to predict severe sepsis patients is investigated. Specifically, InSight is compared with a well established severe sepsis detector in the UCSF electronic health record (EHR).

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
February 2017
Last Updated
4 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Sponsor
Dascena
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All adult patients admitted to the participating units will be eligible.

Exclusion Criteria

  • All patients younger than 18 years of age will be excluded.

Outcomes

Primary Outcomes

Hospital length of stay

Time Frame: Through study completion, an average of 45 days

Secondary Outcomes

  • In-hospital mortality(Through study completion, an average of 45 days)

Study Sites (1)

Loading locations...

Similar Trials